Clear Search

Books+ Search Results

Subject: "Drugs."
Location: Is
Is Is Not
Government Documents
Subject: Is
Is Is Not
United States. Food and Drug Administration

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

1.
Preclinical and clinical testing by the pharmaceutical industry, 1979 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session ... October 11, 1979
Author
United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research
Published
Washington : U.S. Govt. Print. Off., 1979.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:P 91/979
Format
Books
2.
Regulation of new drug R. & D. by the Food and Drug Administration, 1974 : joint hearings before the Subcommittee on Health ... and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session, on examination of new drug research and development by the Food and Drug Administration, September 25 and 27, 1974
Author
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Published
Washington : U. S. Govt. Print. Off., 1975.
Location
Library Shelving Facility (LSF) >> Y 4. L 11/2:D 84/17/974
Format
Books
3.
Regulation of over-the-counter drugs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979
Author
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations
Published
Washington : U.S. Govt. Print. Off., 1979.
Location
Library Shelving Facility (LSF) >> Y 4.In 8/4:96-44
Format
Books
4.
"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978
Author
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations
Published
Washington : U.S. Govt. Print. Off., 1978.
Location
Library Shelving Facility (LSF) >> Y 4.In 8/4:95-140
Format
Books
5.
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-75
Format
Books
6.
A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2003.
Online
Text version:
PDF version: Adobe Acrobat Reader required
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:108-29
Format
Books
7.
Preclinical and clinical testing by the pharmaceutical industry, 1976 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out ..
Author
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Published
Washington : U.S. Govt. Print. Off., 1975-1976.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/2:P 49/
Format
Books
8.
Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1991.
Location
Library Shelving Facility (LSF) >> Y 4.En 2/3:102-45
Format
Books
9.
Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986
Author
United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1987.
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:D 84/21
Format
Books
10.
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-850
Format
Books